Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
Vita means life. In this section, we share stories aimed at providing insight about, and awareness of, the ever-evolving promise of biotechnology.
Visit CSL Behring's newsroom to find recent news releases, archived releases, and media contacts.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
See the research that is done to find out if medical treatments can improve people's health.
Every day at CSL Behring, we work as if someone's life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
Popular search terms:
News from CSL Behring
BROADMEADOWS, AUSTRALIA CSL has today unveiled the future of plasma manufacturing in Australia with the opening of their …
CSL continues to provide medicines to patients around the world.
Osaka, JAPAN and King of Prussia, Pa., USA • The Alliance’s anti-COVID-19 Hyperimmune Globulin (CoVIg-19) medicine is und…
• CSL appointed Trusted Manufacturer for University of Queensland’s “molecular clamp” enabled COVID-19 vaccine candidate • …
Plasma-derived therapeutic with potential to treat serious complications of COVID-19.
Melbourne, Australia - Novel real world evidence for AFSTYLA® [Antihemophilic Factor (Recombinant), Single Chain] and IDEL…
CSL, the parent company of CSL Behring, today announced an AUD$50,000 donation in support of Indonesian earthquake and tsunam…
Americas
Asia Pacific
Middle East
Europe
